Trade Mark Journal No.2026/021 22 May 2026
UK00004384032 7 May 2026 (5)

International priority date claimed: 6 May 2026
(United States of America)
(99806448)
- Class 5
- Pharmaceutical preparations for the treatment of autoimmune diseases and disorders; Pharmaceutical preparations for the treatment of immune system diseases and disorders; antibodies for the treatment of immune system diseases and disorders; antibodies for the treatment of autoimmune diseases and disorders.
Biogen MA Inc.
Representative: Finnegan Europe LLP